Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
6.61
-2.49 (-27.36%)
At close: Aug 4, 2025, 4:00 PM
5.90
-0.71 (-10.74%)
After-hours: Aug 4, 2025, 7:58 PM EDT

Company Description

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.

The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure.

Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.

The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through specialty healthcare distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovak Republic, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom.

The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021.

Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Nuwellis, Inc.
Nuwellis logo
CountryUnited States
Founded1999
IndustryMedical Devices
SectorHealthcare
Employees38
CEOJohn Erb

Contact Details

Address:
12988 Valley View Road
Eden Prairie, Minnesota 55344
United States
Phone952 345 4200
Websitenuwellis.com

Stock Details

Ticker SymbolNUWE
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001506492
CUSIP Number12542Q706
ISIN NumberUS67113Y6032
Employer ID68-0533453
SIC Code3845

Key Executives

NamePosition
John L. ErbChief Executive Officer, President and Chairman of the Board
Robert B. ScottChief Financial Officer
Neil P. Ayotte Esq.Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Kim AndersonVice President of Operations
Betsy RiemenschneiderVice President of Sales
Dr. John Lynn Jefferies FACC, M.B.A., M.D., M.P.H.Chief Medical Officer and Member of Medical Advisory Board
Paul WottaCorporate Controller

Latest SEC Filings

DateTypeTitle
Aug 4, 20258-KCurrent Report
Jul 23, 20258-KCurrent Report
Jul 14, 2025DEF 14AOther definitive proxy statements
Jul 3, 2025PRE 14AOther preliminary proxy statements
Jul 2, 20258-KCurrent Report
Jun 23, 20258-KCurrent Report
Jun 16, 2025SCHEDULE 13DFiling
Jun 13, 2025SCHEDULE 13GFiling
Jun 12, 2025SCHEDULE 13GFiling
Jun 10, 2025424B4Prospectus